{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:08:00Z","timestamp":1792595280587,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":740,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1038\/s41379-020-0636-7","type":"journal-article","created":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T11:10:11Z","timestamp":1596107411000},"page":"42-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["A comparative study of RTK gene status between primary tumors, lymph-node metastases, and Krukenberg tumors"],"prefix":"10.1016","volume":"34","author":[{"given":"Bo","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiusu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoping","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-020-0636-7_bib1","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.5858\/2006-130-1725-AILAKT","article-title":"An in-depth look at Krukenberg tumor","volume":"130","author":"Osama","year":"2006","journal-title":"Arch Pathol Lab Med"},{"key":"10.1038\/s41379-020-0636-7_bib2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/01.pas.0000190787.85024.cb","article-title":"Krukenberg tumors of the ovary: a clinicalpathologic analysis of 120 cases with emphasis on their variable pathologic manifestations","volume":"30","author":"Kiyokawa","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-020-0636-7_bib3","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0090-8258(03)00075-1","article-title":"Metastatic ovarian tumors: a review of 64 cases","volume":"89","author":"Yada-Hashimoto","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1038\/s41379-020-0636-7_bib4","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ygyno.2006.11.005","article-title":"Non-genital tract metastases to the ovaries presented as ovarian tumors in Sweden 1990\u20132003: occurrence, origin and survival compared to ovarian cancer","volume":"105","author":"Skirnisdottir","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1038\/s41379-020-0636-7_bib5","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.cell.2006.11.001","article-title":"Cancer metastasis: buiding a framework","volume":"127","author":"Gupta","year":"2006","journal-title":"Cell"},{"key":"10.1038\/s41379-020-0636-7_bib6","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1006\/gyno.1997.4811","article-title":"Colon cancer with metastasis to the ovary at time of initial diagnosis","volume":"66","author":"Miller","year":"1997","journal-title":"Gynecol Oncol"},{"key":"10.1038\/s41379-020-0636-7_bib7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ejso.2014.12.005","article-title":"Circulating tumour cells and circulating nucleic acids as a measure of tumour dissemination in non-metastatic colorectal cancer surgery","volume":"41","author":"Lim","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"10.1038\/s41379-020-0636-7_bib8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccr.2014.05.002","article-title":"Hematogenous metastasis of ovarian cancer: rethinking mode of spread","volume":"26","author":"Pradeep","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1038\/s41379-020-0636-7_bib9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7150\/jca.4090","article-title":"HER2 as a prognostic marker in gastric cancer\u2014a systematic analysis of data from the literature","volume":"3","author":"Jorgensen","year":"2012","journal-title":"J Cancer"},{"key":"10.1038\/s41379-020-0636-7_bib10","first-page":"3423","article-title":"Clinical significance of hepatocyte growth factor\/c-Met expression in the assessment of gastric cancer progression","volume":"11","author":"Eiichiro","year":"2015","journal-title":"Mol Med Rep."},{"key":"10.1038\/s41379-020-0636-7_bib11","first-page":"5055","article-title":"Amplification of FGFR2 gene in patients with advanced gastric cancer receiving chemotherapy: prevalence and prognostic significance","volume":"35","author":"Shoji","year":"2015","journal-title":"Anticancer Res"},{"key":"10.1038\/s41379-020-0636-7_bib12","doi-asserted-by":"crossref","unstructured":"Marx AH, Zielinski M, Kowitz CM, Dancau AM, Thieltges S, Simon R, et al. Homogeneous EGFR amplification defines a subset of aggressive Barrett's adenocarcinoma with poor prognosis. Histopathology. 2010;57:418\u201326.","DOI":"10.1111\/j.1365-2559.2010.03643.x"},{"key":"10.1038\/s41379-020-0636-7_bib13","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","article-title":"Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial","volume":"376","author":"Bang","year":"2010","journal-title":"Lancet"},{"key":"10.1038\/s41379-020-0636-7_bib14","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1158\/1078-0432.CCR-18-1337","article-title":"A multicenter Phase II study of AMG 337 in patients with MET-amplified gastric\/gastroesophageal junction\/esophageal adenocarcinoma and other MET-amplified solid tumors","volume":"25","author":"Cutsem","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1038\/s41379-020-0636-7_bib15","doi-asserted-by":"crossref","unstructured":"Romond EH, Perez EA, Bryant J, Suman VJ, Geyer Jr CE, Davidson NE. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med. 2005;353:1673\u201384.","DOI":"10.1056\/NEJMoa052122"},{"key":"10.1038\/s41379-020-0636-7_bib16","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1158\/1535-7163.MCT-11-0754","article-title":"MET activation mediates resistance to lapatinib inhibition of HER2-amplified gastric cancer cells","volume":"11","author":"Chen","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"10.1038\/s41379-020-0636-7_bib17","doi-asserted-by":"crossref","first-page":"5145","DOI":"10.1172\/JCI75200","article-title":"Preexisting oncogenic events impact trastuzumab sensitivity in ERBB2-amplified gastroesophageal adenocarcinoma","volume":"124","author":"Kim","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1038\/s41379-020-0636-7_bib18","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1158\/2159-8290.CD-15-0748","article-title":"Molecular heterogeneity and receptor co-amplification drive resistance to targeted therapy in MET-amplified esophagogastric cancer","volume":"5","author":"Kwak","year":"2015","journal-title":"Cancer Discov"},{"key":"10.1038\/s41379-020-0636-7_bib19","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/his.12744","article-title":"Discordant HER2 overexpression in primary and metastatic upper gastrointestinal adenocarcinoma signifies poor prognosis","volume":"68","author":"Hedner","year":"2016","journal-title":"Histopathology"},{"key":"10.1038\/s41379-020-0636-7_bib20","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/SLA.0000000000002042","article-title":"Frequent coamplification of receptor tyrosine kinase and downstream signaling genes in Japanese primary gastric cancer and conversion in matched lymph node metastasis","volume":"267","author":"Silva","year":"2018","journal-title":"Ann Surg"},{"key":"10.1038\/s41379-020-0636-7_bib21","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/PAI.0000000000000347","article-title":"Comparison of a panel of biomarkers between gastric primary cancer and the paired Krukenberg Tumor","volume":"25","author":"Wang","year":"2017","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1038\/s41379-020-0636-7_bib22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ejogrb.2009.11.011","article-title":"The role of cytoreductive surgery for non-genital tract metastatic tumors to the ovaries","volume":"149","author":"Kim","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1038\/s41379-020-0636-7_bib23","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejso.2008.05.006","article-title":"Surgical treatment for patients with different origins of Krukenberg tumors: outcomes and prognostic factors","volume":"35","author":"Jiang","year":"2009","journal-title":"Eur J Surg Oncol"},{"key":"10.1038\/s41379-020-0636-7_bib24","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10585-017-9856-8","article-title":"The pathogenesis, diagnosis, and management of metastatic tumors to the ovary: a comprehensive review","volume":"34","author":"Kubecek","year":"2017","journal-title":"Clin Exp Metastasis"},{"key":"10.1038\/s41379-020-0636-7_bib25","first-page":"123","article-title":"Molecularly targeted therapy for gastrointestinal cancer","volume":"5","author":"Marcus","year":"2013","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1038\/s41379-020-0636-7_bib26","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1056\/NEJMoa071834","article-title":"Cetuximab for the treatment of colorectal cancer","volume":"357","author":"Jonker","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1038\/s41379-020-0636-7_bib27","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.3892\/mco.2015.634","article-title":"Clinical characteristics and prognostic analysis of Krukenberg tumor","volume":"3","author":"Wu","year":"2015","journal-title":"Mol Clin Oncol"},{"key":"10.1038\/s41379-020-0636-7_bib28","doi-asserted-by":"crossref","first-page":"32","DOI":"10.5468\/ogs.2015.58.1.32","article-title":"Krukenberg tumors of gastric origin versus colorectal origin","volume":"58","author":"Jeung","year":"2015","journal-title":"Obstet Gynecol Sci"},{"key":"10.1038\/s41379-020-0636-7_bib29","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s00404-011-1847-4","article-title":"Metastatic neoplasms of the ovaries: a clinicopathological study of 97 cases","volume":"284","author":"Kondi-Pafiti","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"10.1038\/s41379-020-0636-7_bib30","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/IGC.0b013e3181b33cce","article-title":"Secondary ovarian malignancies: frequency, origin, and characteristics","volume":"19","author":"de Waal","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1038\/s41379-020-0636-7_bib31","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000473881","article-title":"Heterogeneity in gastric cancer: from pure morphology to molecular classifications","volume":"85","author":"Gullo","year":"2018","journal-title":"Pathobiology"},{"key":"10.1038\/s41379-020-0636-7_bib32","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/modpathol.2012.205","article-title":"Heterogeneity of ERBB2 in gastric carcinomas: a study of tissue microarray and matched primary and metastatic carcinomas","volume":"26","author":"Cho","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-020-0636-7_bib33","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.humpath.2010.02.018","article-title":"Heterogenous high-level HER-2 amplification in a small subset of colorectal cancers","volume":"41","author":"Marx","year":"2010","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-020-0636-7_bib34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12876-015-0231-4","article-title":"Heterogeneity of amplification of HER2, EGFR, CCND1 and MYC in gastric cancer","volume":"15","author":"Stahl","year":"2015","journal-title":"BMC Gastroenterol"},{"key":"10.1038\/s41379-020-0636-7_bib35","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/bjc.2013.802","article-title":"FGFR2 amplification has prognostic significance in gastric cancer: Results from a large international multicenter study","volume":"110","author":"Su","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1038\/s41379-020-0636-7_bib36","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/gutjnl-2011-301839","article-title":"A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets","volume":"61","author":"Deng","year":"2012","journal-title":"Gut"},{"key":"10.1038\/s41379-020-0636-7_bib37","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.canlet.2014.07.021","article-title":"Mutually exclusive FGFR2, HER2, and KRAS gene amplifications in gastric cancer revealed by multicolour FISH","volume":"353","author":"Das","year":"2014","journal-title":"Cancer Lett"},{"key":"10.1038\/s41379-020-0636-7_bib38","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nature13480","article-title":"Comprehensive molecular characterization of gastric adenocarcinoma","volume":"513","author":"Bass","year":"2014","journal-title":"Nature"},{"key":"10.1038\/s41379-020-0636-7_bib39","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/bjc.2011.322","article-title":"Differential roles of trans-phosphorylated EGFR, HER2, HER3, and RET as heterodimerisation partners of MET in lung cancer with MET amplification","volume":"105","author":"Tanizaki","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1038\/s41379-020-0636-7_bib40","doi-asserted-by":"crossref","DOI":"10.1186\/bcr3208","article-title":"Determining sensitivity and specificity of HER2 testing in breast cancer using a tissue micro-array approach","volume":"14","author":"Dekker","year":"2012","journal-title":"Breast Cancer Res"},{"key":"10.1038\/s41379-020-0636-7_bib41","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.21873\/anticanres.11017","article-title":"Tissue microarray is a reliable tool for the evaluation of HER2 amplification in breast cancer","volume":"36","author":"Furrer","year":"2016","journal-title":"Anticancer Res"},{"key":"10.1038\/s41379-020-0636-7_bib42","first-page":"3313","article-title":"Validation of 2-mm tissue microarray technology in gastric cancer. Agreement of 2-mm TMAs and full sections for Glut-1 and Hif-1 Alpha","volume":"34","author":"Berlth","year":"2014","journal-title":"Anticancer Res"},{"key":"10.1038\/s41379-020-0636-7_bib43","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s12253-013-9654-9","article-title":"HER2 in gastric cancer: an immunohistochemical study on tissue microarrays and the corresponding whole-tissue sections with a supplemental FISH study","volume":"19","author":"Gasljevic","year":"2013","journal-title":"Pathol Oncol Res"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41379-020-0636-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-020-0636-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222003921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222003921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-020-0636-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:32:15Z","timestamp":1760229135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222003921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0893395222003921"],"URL":"https:\/\/doi.org\/10.1038\/s41379-020-0636-7","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comparative study of RTK gene status between primary tumors, lymph-node metastases, and Krukenberg tumors","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-020-0636-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}